Amai Proteins
Precision-fermented sweet proteins to replace sugar in the global food supply
Rehovot, Israel · Founded 2016
- Headquarters
- Rehovot
- Employees
- 11–50
- Founded
- 2016
- Business Model
- B2B
- Website
- amaiproteins.com
About
Amai Proteins is an Israeli food-tech biotechnology company founded in 2016 and headquartered in Rehovot, Israel. The company uses computational protein design, precision fermentation, and food technology to develop novel sweet proteins for the mass food market. Its flagship product, sweelin®, is a next-generation sweet protein derived from the serendipity berry and produced through a natural fermentation process. sweelin® is thousands of times sweeter than sugar, enables 40–70% sugar reduction in food and beverage products, and delivers a clean taste profile with low environmental impact. It is digested like a normal protein with no adverse metabolic interactions. sweelin® has received FDA GRAS (Generally Recognized as Safe) approval in the United States and food additive approval from Singapore's Food Agency. Amai's multidisciplinary team combines expertise in computational biophysics, cloud computing, bioinformatics, and food science. The company has partnerships and collaborations with PepsiCo, Danone, Ocean Spray, and academic institutions including Stanford and UCSF.
Summary
Amai Proteins is a Biotech company based in Rehovot, Israel, founded in 2016.
Tech & App Stack
4 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.